You are here: Home » News-CM » Companies » News
Business Standard

Natco Pharma update on its key technical product - Chlorantraniliprole

Capital Market 

Natco Pharma announced a key technical product from its Crop Health Sciences (CHS) division for Chlorantraniliprole (CTPR), a broad spectrum insecticide used in several crops, and is hoping to bring formulations based on this product with affordability and accessibility to farmers across the country. NATCO is awaiting regulatory approval of the CTPR product.

CTPR is an active ingredient used in products commercialized by FMC under their brands Coragen & Ferterra.

The sales generated from CTPR containing products in India, inclusive of third-party marketing companies, as per declaration given by FMC is estimated to be Rs 1540 crore in 2016. NATCO has filed a suit for declaration of freedom to use of CTPR, at the City Civil Court, Hyderabad, in the month of September 2019. FMC has counter-sued before the Delhi High Court, in November 2019, claiming patent infringement.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, November 11 2019. 15:44 IST